High immunogenicity and good tolerability of a new hepatitis A vaccine candidate

Vaccine

Volumn 14, Issue 12, 1996, Pages 1089-1091

  Langer, B C A ^a   Lovestad A ^a   Frosner G G ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Hepatitis A vaccine; Immunogenicity; Tolerability

Indexed keywords

HEPATITIS ANTIBODY;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VACCINATION;

EID: 0030581351     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(96)00080-1     Document Type: Article

References (7)

1. 1 Winokur, P.L. and Stapleton, J.T. Immunoglobulin prophylaxis for hepatitis A. Clin. Infect. Dis. 1992, 14, 580-586
2. 2 Andre, F.E., D'Hondt, E., Delem, A. and Safary, A. Clinical assessment of safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings. Vaccine 1992, 10suppl. 1, 160-168
3. 3 Clemens, R., Safary, A., Hepburn, A., Roche, C., Stanbury, W.J. and Andre, F.E. Clinical experience with an inactivated hepatitis A vaccine. J. Infect. Dis. 1995, 171suppl. 1, 44-49
4. 4 Innis, B.L., Snithbnan, R., Kunasol, P. et al. Field efficacy trial of inactivated hepatitis A vaccine among children in Thailand. J. Am. Med. Assoc. 1994, 27117, 1328-1334
5. 5 Just, M. and Berger, R. Reactogenicity and immunogenicity of inactivated hepatitis A vaccine. Vaccine 1992, 10suppl. 1, 110-113
6. 6 Nalin, D.R., Kuter, B.J., Brown, L. et al. Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview. J. Hepat. 1993, 18suppl. 2, 51-55
7. 7 Werzberger, A., Mensch, B., Kuter, B. et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N. Engl. J. Med. 1992, 327, 453-457